Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2024-04-25 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学科技股份有限公司2023年度独立董事述职报告-解亘
Regulatory Filings
2024-04-25 Chinese
南微医学科技股份有限公司2023年度独立董事述职报告-楼佩煌（离任）
Regulatory Filings
2024-04-25 Chinese
南京证券股份有限公司关于南微医学科技股份有限公司2023 年度募集资金存放与实际使用情况的专项核查报告
Regulatory Filings
2024-04-25 Chinese
南微医学科技股份有限公司关于续聘2024年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of the company's audit firm for the 2024 fiscal year. It details the qualifications, integrity, and independence of the audit firm, the audit fees, and the approval process by the board and shareholders. It does not contain an audit report itself, nor does it present financial statements or audit results. Instead, it is a formal announcement about the selection and continuation of the audit service provider. Given the content and length (2415 characters), this fits the category of an Audit Report / Information announcement, specifically about the audit firm appointment, which is classified under AR (Audit Report / Information). FY 2024
2024-04-25 Chinese
南微医学科技股份有限公司第三届监事会第十四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of 南微医学科技股份有限公司 regarding multiple reports and proposals related to the company's 2023 annual activities and 2024 first quarter. It references the 2023 Annual Report, 2023 Annual Financial Statements, 2023 Social Responsibility Report, 2024 Q1 Report, and other related documents. However, the document itself is a meeting resolution summary and does not contain the full financial statements or detailed report content. It also states that the detailed reports are published separately on the Shanghai Stock Exchange website. The document length is 3044 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document is an announcement of the Supervisory Board's resolutions and references to reports rather than the reports themselves. The best fitting category is Regulatory Filings (RNS) as it is a formal regulatory announcement that does not fit other specific categories like Annual Report (10-K) or Interim Report (IR).
2024-04-25 Chinese
南京证券股份有限公司关于南微医学科技股份有限公司2023 年度募集资金存放与实际使用情况的专项核查报告
Regulatory Filings
2024-04-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.